Related Experiment Video

Updated: Apr 27, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

2.6K

Cerebral microbleeds: overview and implications in cognitive impairment

Sergi Martinez-Ramirez1, Steven M Greenberg1, Anand Viswanathan1

  • 1Philip J. Kistler Stroke Research Center, Massachusetts General Hospital, 175 Cambridge Street Suite 300, Boston, MA 02114, USA.

Alzheimer'S Research & Therapy
|July 3, 2014
PubMed

Insights

Cerebral microbleeds (MBs) are small brain hemorrhages detectable by MRI. Their clinical significance and links to conditions like Alzheimer's disease are actively researched.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Vascular Neurology

Background:

  • Cerebral microbleeds (MBs) are small hemorrhages in the brain, often linked to small vessel disease.
  • Magnetic resonance imaging (MRI) is crucial for detecting MBs due to their paramagnetic properties.
  • MBs are increasingly found in diverse populations, including healthy individuals, prompting research into their significance.

Purpose of the Study:

  • To review the current understanding of cerebral microbleed pathophysiology.
  • To discuss the clinical and prognostic implications of MBs.
  • To explore the association between lobar MBs, cerebral amyloid angiopathy, and Alzheimer's disease.

Main Methods:

  • Review of existing epidemiological and clinical studies utilizing MRI for MB detection.
  • Analysis of research on the topographic distribution of MBs and associated vasculopathies.
  • Synthesis of current knowledge on MB pathophysiology and clinical relevance.

Main Results:

  • MBs are common findings across various populations, detectable via specific MRI sequences.
  • The location of MBs may indicate specific underlying vascular abnormalities.
  • The clinical and prognostic impact of MBs remains an area of active investigation.

Conclusions:

  • Cerebral microbleeds are significant markers of small vessel disease.
  • Further research is needed to fully elucidate the clinical and prognostic value of MBs.
  • Understanding the link between lobar MBs, CAA, and Alzheimer's disease is a key research focus.

More Related Videos

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats06:39

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

6.1K
Assessing Cortical Cerebral Microinfarcts on High Resolution MR Images08:39

Assessing Cortical Cerebral Microinfarcts on High Resolution MR Images

Published on: November 20, 2015

12.8K

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
18
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
14
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
31
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
16
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
33
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K